Immediate Impact

2 by Nobel laureates 4 from Science/Nature 61 standout
Sub-graph 1 of 22

Citing Papers

Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial
2019 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
1 intermediate paper

Works of Roy H. Leiboff being referenced

Hemorrhagic Events during Therapy with Recombinant Tissue-Type Plasminogen Activator, Heparin, and Aspirin for Acute Myocardial Infarction
1991

Author Peers

Author Last Decade Papers Cites
Roy H. Leiboff 710 367 290 18 975
Şengül Çehreli 732 198 197 40 1.0k
Martin Fleisch 618 409 452 38 1.1k
Janet Strain 827 213 182 17 938
Marcel H. J. Eijgelshoven 888 594 519 16 1.1k
Kazuteru Fujimoto 614 250 250 34 1.0k
Juan R. Serur 543 278 269 30 1000
K Matsuyama 642 243 317 16 848
Ömer Şahin 607 152 163 37 966
Jan Res 826 352 383 14 964
Douglas Ing 425 367 214 23 980

All Works

Loading papers...

Rankless by CCL
2026